Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins. / Sørensen, Mette; Tulstrup, Morten; Hansen, Jakob Werner; Weischenfeldt, Joachim; Gronbaek, Kirsten; Christensen, Kaare.

In: HemaSphere, Vol. 6, No. 9, 768, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sørensen, M, Tulstrup, M, Hansen, JW, Weischenfeldt, J, Gronbaek, K & Christensen, K 2022, 'Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins', HemaSphere, vol. 6, no. 9, 768. https://doi.org/10.1097/HS9.0000000000000768

APA

Sørensen, M., Tulstrup, M., Hansen, J. W., Weischenfeldt, J., Gronbaek, K., & Christensen, K. (2022). Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins. HemaSphere, 6(9), [768]. https://doi.org/10.1097/HS9.0000000000000768

Vancouver

Sørensen M, Tulstrup M, Hansen JW, Weischenfeldt J, Gronbaek K, Christensen K. Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins. HemaSphere. 2022;6(9). 768. https://doi.org/10.1097/HS9.0000000000000768

Author

Sørensen, Mette ; Tulstrup, Morten ; Hansen, Jakob Werner ; Weischenfeldt, Joachim ; Gronbaek, Kirsten ; Christensen, Kaare. / Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins. In: HemaSphere. 2022 ; Vol. 6, No. 9.

Bibtex

@article{e8e189b0c1974509b3785226a4694fc0,
title = "Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins",
abstract = "Clonal hematopoiesis of indeterminate potential (CHIP) is common in the elderly and has been reported to associate with accelerated epigenetic age (AgeAccel), especially intrinsic (ie, cell-type independent) AgeAccel and to a lesser degree extrinsic AgeAccel, which reflects the immune-cell composition of the peripheral blood. We investigated the association between CHIP occurrence and AgeAccel in 154 Danish twin pairs aged 73-90 years (mean 79), using both individual-level and intrapair analyses, the latter to control for shared genetic and environmental factors. Of 308 individuals, 116 carried a CHIP mutation. CHIP carriers had non-significantly increased AgeAccel compared with non-carriers; the strongest association was for the Intrinsic Epigenetic Age Acceleration (IEAA) estimator (CHIP carriers 1.4 years older, P = 0.052). In intrapair analyses, the extrinsic Hannum age estimator showed the strongest association (1.6 years older, P = 0.027). In mutation-specific analyses, TET2 mutations were associated with the extrinsic Hannum age estimator in both individual-level (3.0 years older, P = 0.003) and intrapair analyses (2.8 years older, P = 0.05). DNMT3A mutations were associated with IEAA in individual-level (1.9 years older, P = 0.034) but not intrapair analysis (0.9 years, P = 0.41). Analyses of logit-transformed variant allele frequency were generally consistent with these results. Together, these observations indicate that different factors may be driving the expansion of DNMT3A and TET2 clones, respectively. Finally, CHIP carriers accelerated in both the Hannum and the GrimAge age estimators did not have an increased mortality risk in our cohort followed for 22 years (HR = 1.02, P = 0.93), hence not replicating the stratification model proposed by Nachun et al.",
keywords = "ATHEROSCLEROSIS, MUTATIONS",
author = "Mette S{\o}rensen and Morten Tulstrup and Hansen, {Jakob Werner} and Joachim Weischenfeldt and Kirsten Gronbaek and Kaare Christensen",
year = "2022",
doi = "10.1097/HS9.0000000000000768",
language = "English",
volume = "6",
journal = "HemaSphere",
issn = "2572-9241",
publisher = "Lippincott, Williams & Wilkins",
number = "9",

}

RIS

TY - JOUR

T1 - Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins

AU - Sørensen, Mette

AU - Tulstrup, Morten

AU - Hansen, Jakob Werner

AU - Weischenfeldt, Joachim

AU - Gronbaek, Kirsten

AU - Christensen, Kaare

PY - 2022

Y1 - 2022

N2 - Clonal hematopoiesis of indeterminate potential (CHIP) is common in the elderly and has been reported to associate with accelerated epigenetic age (AgeAccel), especially intrinsic (ie, cell-type independent) AgeAccel and to a lesser degree extrinsic AgeAccel, which reflects the immune-cell composition of the peripheral blood. We investigated the association between CHIP occurrence and AgeAccel in 154 Danish twin pairs aged 73-90 years (mean 79), using both individual-level and intrapair analyses, the latter to control for shared genetic and environmental factors. Of 308 individuals, 116 carried a CHIP mutation. CHIP carriers had non-significantly increased AgeAccel compared with non-carriers; the strongest association was for the Intrinsic Epigenetic Age Acceleration (IEAA) estimator (CHIP carriers 1.4 years older, P = 0.052). In intrapair analyses, the extrinsic Hannum age estimator showed the strongest association (1.6 years older, P = 0.027). In mutation-specific analyses, TET2 mutations were associated with the extrinsic Hannum age estimator in both individual-level (3.0 years older, P = 0.003) and intrapair analyses (2.8 years older, P = 0.05). DNMT3A mutations were associated with IEAA in individual-level (1.9 years older, P = 0.034) but not intrapair analysis (0.9 years, P = 0.41). Analyses of logit-transformed variant allele frequency were generally consistent with these results. Together, these observations indicate that different factors may be driving the expansion of DNMT3A and TET2 clones, respectively. Finally, CHIP carriers accelerated in both the Hannum and the GrimAge age estimators did not have an increased mortality risk in our cohort followed for 22 years (HR = 1.02, P = 0.93), hence not replicating the stratification model proposed by Nachun et al.

AB - Clonal hematopoiesis of indeterminate potential (CHIP) is common in the elderly and has been reported to associate with accelerated epigenetic age (AgeAccel), especially intrinsic (ie, cell-type independent) AgeAccel and to a lesser degree extrinsic AgeAccel, which reflects the immune-cell composition of the peripheral blood. We investigated the association between CHIP occurrence and AgeAccel in 154 Danish twin pairs aged 73-90 years (mean 79), using both individual-level and intrapair analyses, the latter to control for shared genetic and environmental factors. Of 308 individuals, 116 carried a CHIP mutation. CHIP carriers had non-significantly increased AgeAccel compared with non-carriers; the strongest association was for the Intrinsic Epigenetic Age Acceleration (IEAA) estimator (CHIP carriers 1.4 years older, P = 0.052). In intrapair analyses, the extrinsic Hannum age estimator showed the strongest association (1.6 years older, P = 0.027). In mutation-specific analyses, TET2 mutations were associated with the extrinsic Hannum age estimator in both individual-level (3.0 years older, P = 0.003) and intrapair analyses (2.8 years older, P = 0.05). DNMT3A mutations were associated with IEAA in individual-level (1.9 years older, P = 0.034) but not intrapair analysis (0.9 years, P = 0.41). Analyses of logit-transformed variant allele frequency were generally consistent with these results. Together, these observations indicate that different factors may be driving the expansion of DNMT3A and TET2 clones, respectively. Finally, CHIP carriers accelerated in both the Hannum and the GrimAge age estimators did not have an increased mortality risk in our cohort followed for 22 years (HR = 1.02, P = 0.93), hence not replicating the stratification model proposed by Nachun et al.

KW - ATHEROSCLEROSIS

KW - MUTATIONS

U2 - 10.1097/HS9.0000000000000768

DO - 10.1097/HS9.0000000000000768

M3 - Journal article

C2 - 36046215

VL - 6

JO - HemaSphere

JF - HemaSphere

SN - 2572-9241

IS - 9

M1 - 768

ER -

ID: 346076035